Frontlight ResearchEarly access
Trial site
Ospedale Giovan Battista Morgagni-Luigi Pierantoni Di Forlì
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Idiopathic pulmonary fibrosis5 trials
- Sarcoidosis2 trials
- Atrial fibrillation1 trial
- Coronary artery disease1 trial
- Stroke1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 34 trials
- Phase 1/22 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Bristol-Myers Squibb Services Unlimited Company2 trials
- Arrowhead Pharmaceuticals1 trial
- aTyr Pharma, Inc.1 trial
- Boehringer Ingelheim1 trial
- Genentech Inc.1 trial
- and 2 more
Running trials
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation1 recruiting
- Coronary artery disease1 recruiting
- Sarcoidosis1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
Completed
Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026